Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Raynaud's disease.

Literature DB >> 3160308

Raynaud's disease.

Abstract

We report five children who presented with Raynaud's disease in whom we could find no clinical, haematological, or immunological evidence of a collagen disorder. Oral phenoxybenzamine proved useful for maintenance treatment in most, with infusions of prostacyclin, nitroprusside, and ketanserin during acute attacks.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1985 PMID： 3160308 PMCID： PMC1777375 DOI： 10.1136/adc.60.6.537

Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791

18 in total

1. Raynaud's disease; a study of criteria for prognosis.

Authors: A BLAIN; F A COLLER; G B CARVER
Journal: Surgery Date: 1951-03 Impact factor: 3.982

2. Acquired right ventricular outflow obstruction in a child with neurofibromatosis.

Authors: G C Rosenquist; L J Krovetz; J A Haller; A L Simon; G A Bannayan
Journal: Am Heart J Date: 1970-01 Impact factor: 4.749

3. Raynaud's phenomenon preceding acute lymphocytic leukemia.

Authors: K R Powell
Journal: J Pediatr Date: 1973-03 Impact factor: 4.406

4. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.

Authors: R J Rodeheffer; J A Rommer; F Wigley; C R Smith
Journal: N Engl J Med Date: 1983-04-14 Impact factor: 91.245

5. Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.

Authors: O K Roald; E Seem
Journal: Br Med J (Clin Res Ed) Date: 1984-09-08

6. Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis.

Authors: R P Erickson; J Woolliscroft; R J Allen
Journal: Clin Genet Date: 1980-09 Impact factor: 4.438

7. Raynaud's disease in children.

Authors: W G Guntheroth; B C Morgan; J A Harbinson; G L Mullins
Journal: Circulation Date: 1967-11 Impact factor: 29.690

8. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.

Authors: J J Belch; P Newman; J K Drury; F McKenzie; H Capell; P Leiberman; C D Forbes; C R Prentice
Journal: Lancet Date: 1983-02-12 Impact factor: 79.321

Raynaud's disease.

1. Raynaud's disease; a study of criteria for prognosis.

2. Acquired right ventricular outflow obstruction in a child with neurofibromatosis.

3. Raynaud's phenomenon preceding acute lymphocytic leukemia.

4. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.

5. Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.

6. Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis.

7. Raynaud's disease in children.

8. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.

9. Raynaud's disease among women and girls.

Review 10. Systemic sclerosis--a microvascular disorder?

1. Acrocyanosis due to imipramine.

Review 2. Management of Raynaud's phenomenon. Focus on newer treatments.